Patient Frailty Should Be Used to Individualize Treatment Decisions in Primary Hyperparathyroidism

被引:0
|
作者
Carolyn D. Seib
Kathryn Chomsky-Higgins
Jessica E. Gosnell
Wen T. Shen
Insoo Suh
Quan-Yang Duh
Emily Finlayson
机构
[1] University of California,Department of Surgery
[2] San Francisco,undefined
来源
World Journal of Surgery | 2018年 / 42卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3215 / 3222
页数:7
相关论文
共 50 条
  • [1] Patient Frailty Should Be Used to Individualize Treatment Decisions in Primary Hyperparathyroidism
    Seib, Carolyn D.
    Chomsky-Higgins, Kathryn
    Gosnell, Jessica E.
    Shen, Wen T.
    Suh, Insoo
    Duh, Quan-Yang
    Finlayson, Emily
    WORLD JOURNAL OF SURGERY, 2018, 42 (10) : 3215 - 3222
  • [2] Predicting the Risk of Untreated Primary Hyperparathyroidism and Parathyroidectomy to Inform and Individualize Treatment Decisions
    Delaney, Lia D.
    Day, Heather S.
    Suh, Insoo
    Cisco, Robin M.
    Harris, Alex
    Tamura, Manjula
    Seib, Carolyn D.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S124 - S125
  • [3] How should we manage a patient with asymptomatic primary hyperparathyroidism?
    Triponez, F.
    Mirallie, E.
    Brunaud, L.
    ANNALES DE CHIRURGIE, 2006, 131 (08): : 451 - 454
  • [4] Frailty assessment to individualize treatment in older patients with lymphoma
    Hormigo-Sanchez, Ana I.
    Lopez-Garcia, Alberto
    Mahillo-Fernandez, Ignacio
    Askari, Elham
    Morillo, Daniel
    Perez-Saez, Maria A.
    Riesco, Miriam
    Urrutia, Celia
    Martinez-Peromingo, Francisco J.
    Cordoba, Raul
    Gonzalez-Montalvo, Juan I.
    EUROPEAN GERIATRIC MEDICINE, 2023, 14 (06) : 1393 - 1402
  • [5] Frailty assessment to individualize treatment in older patients with lymphoma
    Ana I. Hormigo-Sanchez
    Alberto Lopez-Garcia
    Ignacio Mahillo-Fernandez
    Elham Askari
    Daniel Morillo
    María A. Perez-Saez
    Miriam Riesco
    Celia Urrutia
    Francisco J. Martinez-Peromingo
    Raúl Cordoba
    Juan I. Gonzalez-Montalvo
    European Geriatric Medicine, 2023, 14 : 1393 - 1402
  • [6] Should the duration of primary hyperparathyroidism impact guidelines for evaluation and treatment?
    Randle, Reese W.
    Lee, Cortney Y.
    SURGERY, 2019, 165 (01) : 105 - 106
  • [7] Individualize Treatment With Aspirin for Primary Prevention
    Kostis, John B.
    ANNALS OF INTERNAL MEDICINE, 2019, 171 (08) : 583 - 584
  • [8] TREATMENT WITH SALMON CALCITONIN OF A PATIENT WITH SUSPECTED PRIMARY HYPERPARATHYROIDISM
    MORII, H
    HAMADA, N
    NISHIZAWA, Y
    OKAMOTO, T
    WADA, M
    OCHI, H
    CALCIFIED TISSUE RESEARCH, 1975, 19 (03): : 234 - 235
  • [9] SURGICAL-TREATMENT OF PRIMARY HYPERPARATHYROIDISM IN THE ELDERLY PATIENT
    NUDELMAN, I
    DEUTSCH, AA
    REISS, R
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1983, 19 (02): : 150 - 152
  • [10] SURGICAL-TREATMENT OF PRIMARY HYPERPARATHYROIDISM IN THE ELDERLY PATIENT
    AUGUSTIN, N
    MEDIZINISCHE WELT, 1990, 41 (07): : 611 - 615